未登录

A

Andrew R. MacRae

University of Manitoba

H指数:18

被引数:1,302

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10 years

CLINICA CHIMICA ACTA

IF2.9

2017-12-0126

PREAI

Letter by Kavsak and MacRae Regarding Article, Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction

IF38.6

2012-02-147

OAAI

Increasing Cardiac Troponin Changes Measured by a Research High-Sensitivity Troponin I Assay: Absolute vs Percentage Changes and Long-Term Outcomes in a Chest Pain Cohort

CLINICAL CHEMISTRY

IF6.3

2010-12-0135

PREAI

2007 Universal Myocardial Infarction Definition Change Criteria for Risk Stratification by Use of a High-Sensitivity Cardiac Troponin I Assay

CLINICAL CHEMISTRY

IF6.3

2010-03-0129

OAAI

Another potential marker linking gender and cardiac mortality: PAPP-A - A new marker in risk stratification for women presenting with chest pain

CLINICA CHIMICA ACTA

IF2.9

2009-10-013

PREAI

Short- and Long-Term Risk Stratification Using a Next-Generation, High-Sensitivity Research Cardiac Troponin I (hs-cTnI) Assay in an Emergency Department Chest Pain Population

CLINICAL CHEMISTRY

IF6.3

2009-10-0180

OAAI

Analytic and Clinical Utility of a Next-Generation, Highly Sensitive Cardiac Troponin I Assay for Early Detection of Myocardial Injury

CLINICAL CHEMISTRY

IF6.3

2009-03-01153

OA

Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?

CLINICAL CHEMISTRY

IF6.3

2008-04-0115

OAAI

Upstream markers provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes

CLINICA CHIMICA ACTA

IF2.9

2008-01-0116

OAAI

Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide

CLINICAL CHEMISTRY

IF6.3

2007-12-0159

OAAI

Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction

CLINICA CHIMICA ACTA

IF2.9

2007-05-0150

PREAI

Authors' response to Apple editorial

CLINICA CHIMICA ACTA

IF2.9

2007-05-010

PREAI

Long-term health outcomes associated with detectable troponin I concentrations

CLINICAL CHEMISTRY

IF6.3

2007-02-0166

OAAI

Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naive emergency department patients

CLINICAL CHEMISTRY

IF6.3

2006-11-0118

OAAI

The. impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction

AMERICAN HEART JOURNAL

IF3.5

2006-07-0167

PREAI

Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies

CLINICAL CHEMISTRY

IF6.3

2006-05-01167

OA

Outcome validation of the Beckman Coulter Access analyzer in a second-trimester Down syndrome serum screening application

CLINICAL CHEMISTRY

IF6.3

2003-01-0117

OAAI